tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Edward Nash, 133 are a BUY (89.86%), 13 are a HOLD (8.78%), 2 are a SELL (1.35%).
Analyst Edward Nash works at CANACCORD with a stock forecast success ratio of 42.7% fulfilled within 229.06 days on average.
Edward Nash’s has documented 294 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RANI, Rani Therapeutics Holdings at 27-Mar-2024.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 6/6/2017. The price target of $69.95 was fulfilled within 1 day with a profit of $6.38 (10.04%) receiving and performance score of 100.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3
$2.89 (2627.27%)
10
5 years 5 months 12 days ago
0/5 (0%)
$1.07 (55.44%)
Hold
3
$2.89 (2627.27%)
19
5 years 5 months 13 days ago
0/5 (0%)
$1 (50.00%)
Hold
5 years 5 months 16 days ago
1/4 (25%)
$8.57 (47.07%)
31
Hold
8
$7.89 (7172.73%)
20
5 years 5 months 19 days ago
1/5 (20%)
$4.75 (146.15%)
41
Buy
22
$21.89 (19900.00%)
28
6 years 2 months 11 days ago
1/3 (33.33%)
$11.09 (101.65%)
22
Which stock is Edward Nash is most bullish on?
Which stock is Edward Nash is most reserved on?
What Year was the first public recommendation made by Edward Nash?
